Markets a wearable electric field device for treating glioblastoma brain cancer.
Industry: Health Care
First Day Return: -16.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/31/2015 |
Offer Price | $22.00 |
Price Range $23.00 - $24.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $165 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/01/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $165 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | St Helier, Jersey |
Founded | 2000 |
Employees at IPO | 258 |
Website www.novocure.com |